This is a preview of subscription content, log in via an institution to check access.
References
Mumcuoglu KY. Prevention and treatment of head lice in children. Paediatr Drugs 1999 Jul–Sep; 1(3): 211–8
British National Formulary. No. 38. London: The Pharmaceutical Press, 1999 Sep: 522-4
Tabashnik BE. Modeling and evaluation of resistance management tactics. In: Roush RT, Tabashnik BE, editors. Pesticide resistance in arthropods. New York: Chapman and Hall, 1990: 153–82
Altschuler DZ, Kenney LE. Pediculicide performance, profit, and the public health. Arch Dermatol 1988; 122: 260
Yeung SPS. Back to school. NZ Pharmacy 2000 Feb; 21-2
Brown K. Management of head lice and other human parasites. Prescriber 1999 Sep 5: 119–22
Ibarra J, Hall DMB. Head lice in schoolchildren. Arch Dis Child 1996; 75: 471–3
Lyons P. The most dangerous medicine. Available from: National Pediculosis Association, http://www.headlice.org [Accessed 1999 Jul 2]
POM-to-P shift proposed for budesonide and P-to-POM for carbaryl. Pharm J 1995; 255: 138
Vander Stichele RH, Dezeure EM, Bogaert MG. Systematic review of clinical efficacy of topical treatments for head lice. BMJ 1995 Sep 2; 331: 604–8
Rights and permissions
About this article
Cite this article
Heads being scratched over worldwide head louse problem. Drugs Ther. Perspect 15, 9–13 (2000). https://doi.org/10.2165/00042310-200015080-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200015080-00004